Optical wireless communications (OWCs) refer to wireless communication technologies which utilize optical carriers in infrared, visible light, or ultraviolet bands of electromagnetic spectrum. For ...the sake of an OWC link design and performance evaluation, a comprehensive understanding and an accurate prediction of link behavior are indispensable. Therefore, accurate and efficient channel models are crucial for the OWC link design. This paper first provides a brief history of OWCs. It also considers OWC channel scenarios and their utilization trade-off in terms of optical carrier, range, mobility, and power efficiency. Furthermore, the main optical channel characteristics that affect the OWC link performance are investigated. A comprehensive overview of the most important OWCs channel measurement campaigns and channel models, primarily for wireless infrared communications and visible light communications, are presented. OWCs channel models are further compared in terms of computation speed, complexity, and accuracy. The survey considers indoor, outdoor, underground, and underwater communication environments. Finally, future research directions in OWCs channel measurements and models are addressed.
In this paper, we propose a new regular-shaped geometry-based stochastic model (RS-GBSM) for non-isotropic scattering wideband multiple-input multiple-output vehicle-to-vehicle (V2V) Ricean fading ...channels. By correcting the unrealistic assumption widely used in current RS-GBSMs, the proposed model can more practically study the impact of the vehicular traffic density on channel statistics for different time delays. From the proposed model, we derive the Doppler power spectral density (PSD) and find that highly dynamic Doppler spectrum appears for V2V channels. Excellent agreement is achieved between the derived Doppler PSD and measured data, demonstrating the utility of the proposed model. To combat the intercarrier interference (ICI) caused by highly dynamic Doppler spectrum in real orthogonal frequency division multiplexing based V2V systems, this paper proposes a new type of ICI cancellation scheme, named as precoding based cancellation (PBC) scheme. The proposed scheme can be easily implemented into real V2V systems with the same ICI mitigation performance as the current best ICI cancellation scheme that has high complexity. To further improve the performance of the proposed PBC scheme, a new phase rotation aided (PRA) method, namely constant PRA (CPRA) method, is proposed. Compared with the existing PRA method, the CPRA method has better performance and much less implementation complexity. Therefore, the proposed PBC scheme with the CPRA method is the best ICI cancellation scheme for real V2V systems.
Due to the agile maneuverability, unmanned aerial vehicles (UAVs) have shown great promise for on-demand communications. In practice, UAV-aided aerial base stations are not separate. Instead, they ...rely on existing satellites/terrestrial systems for spectrum sharing and efficient backhaul. In this case, how to coordinate satellites, UAVs and terrestrial systems is still an open issue. In this paper, we deploy UAVs for coverage enhancement of a hybrid satellite-terrestrial maritime communication network. Using a typical composite channel model including both large-scale and small-scale fading, the UAV trajectory and in-flight transmit power are jointly optimized, subject to constraints on UAV kinematics, tolerable interference, backhaul, and the total energy of the UAV for communications. Different from existing studies, only the location-dependent large-scale channel state information (CSI) is assumed available, because it is difficult to obtain the small-scale CSI before takeoff in practice and the ship positions can be obtained via the dedicated maritime Automatic Identification System. The optimization problem is non-convex. We solve it by using problem decomposition, successive convex optimization and bisection searching tools. Simulation results demonstrate that the UAV fits well with existing satellite and terrestrial systems, using the proposed optimization framework.
Current fifth generation (5G) cellular networks mainly focus on the terrestrial scenario. Due to the difficulty of deploying communications infrastructure on the ocean, the performance of existing ...maritime communication networks (MCNs) is far behind 5G. This problem can be solved by using unmanned aerial vehicles (UAVs) as agile aerial platforms to enable on-demand maritime coverage, as a supplement to marine satellites and shore-based terrestrial based stations (TBSs). In this article, we study the integration of UAVs with existing MCNs, and investigate the potential gains of hybrid satellite-UAV-terrestrial networks for maritime coverage. Unlike the terrestrial scenario, vessels on the ocean keep to sea lanes and are sparsely distributed. This provides new opportunities to ease the scheduling of UAVs. Also, new challenges arise due to the more complicated maritime prorogation environment, as well as the mutual interference between UAVs and existing satellites/TBSs. We discuss these issues and show possible solutions considering practical constraints.
Gastric cancer is a deadly disease and remains the third leading cause of cancer-related death worldwide. The 5-year overall survival rate of patients with early-stage localized gastric cancer is ...more than 60%, whereas that of patients with distant metastasis is less than 5%. Surgical resection is the best option for early-stage gastric cancer, while chemotherapy is mainly used in the middle and advanced stages of this disease, despite the frequently reported treatment failure due to chemotherapy resistance. Therefore, there is an unmet medical need for identifying new biomarkers for the early diagnosis and proper management of patients, to achieve the best response to treatment. Long non-coding RNAs (lncRNAs) in body fluids have attracted widespread attention as biomarkers for early screening, diagnosis, treatment, prognosis, and responses to drugs due to the high specificity and sensitivity. In the present review, we focus on the clinical potential of lncRNAs as biomarkers in liquid biopsies in the diagnosis and prognosis of gastric cancer. We also comprehensively discuss the roles of lncRNAs and their molecular mechanisms in gastric cancer chemoresistance as well as their potential as therapeutic targets for gastric cancer precision medicine.
Celotno besedilo
Dostopno za:
DOBA, IZUM, KILJ, NUK, PILJ, PNG, SAZU, SIK, UILJ, UKNU, UL, UM, UPUK
Objectives
This study was conducted in order to establish and validate a radiomics model for predicting lymph node (LN) metastasis of intrahepatic cholangiocarcinoma (IHC) and to determine its ...prognostic value.
Methods
For this retrospective study, a radiomics model was developed in a primary cohort of 103 IHC patients who underwent curative-intent resection and lymphadenectomy. Radiomics features were extracted from arterial phase computed tomography (CT) scans. A radiomics signature was built based on highly reproducible features using the least absolute shrinkage and selection operator (LASSO) method. Multivariate logistic regression analysis was adopted to establish a radiomics model incorporating radiomics signature and other independent predictors. Model performance was determined by its discrimination, calibration, and clinical usefulness. The model was internally validated in 52 consecutive patients.
Results
The radiomics signature comprised eight LN-status–related features and showed significant association with LN metastasis in both cohorts (
p
< 0.001). A radiomics nomogram that incorporates radiomics signature and CA 19-9 level showed good calibration and discrimination in the primary cohort (AUC 0.8462) and validation cohort (AUC 0.8921). Promisingly, the radiomics nomogram yielded an AUC of 0.9224 in the CT-reported LN-negative subgroup. Decision curve analysis confirmed the clinical utility of this nomogram. High risk for metastasis portended significantly lower overall and recurrence-free survival than low risk for metastasis (both
p
< 0.001). The radiomics nomogram was an independent preoperative predictor of overall and recurrence-free survival.
Conclusions
Our radiomics model provided a robust diagnostic tool for prediction of LN metastasis, especially in CT-reported LN-negative IHC patients, that may facilitate clinical decision-making.
Key Points
• The radiomics nomogram showed good performance for prediction of LN metastasis in IHC patients, particularly in the CT-reported LN-negative subgroup.
• Prognosis of high-risk patients remains dismal after curative-intent resection.
• The radiomics model may facilitate clinical decision-making and define patient subsets benefiting most from surgery.
Fifth generation (5G) mobile communication systems have entered the stage of commercial deployment, providing users with new services, improved user experiences as well as a host of novel ...opportunities to various industries. However, 5G still faces many challenges. To address these challenges, international industrial, academic, and standards organizations have commenced research on sixth generation (6G) wireless communication systems. A series of white papers and survey papers have been published, which aim to define 6G in terms of requirements, application scenarios, key technologies, etc. Although ITU-R has been working on the 6G vision and it is expected to reach a consensus on what 6G will be by mid-2023, the related global discussions are still wide open and the existing literature has identified numerous open issues. This paper first provides a comprehensive portrayal of the 6G vision, technical requirements, and application scenarios, covering the current common understanding of 6G. Then, a critical appraisal of the 6G network architecture and key technologies is presented. Furthermore, existing testbeds and advanced 6G verification platforms are detailed for the first time. In addition, future research directions and open challenges are identified to stimulate the on-going global debate. Finally, lessons learned to date concerning 6G networks are discussed.
Existing clinical studies supported the potential efficacy of mesenchymal stromal cells as well as derived exosomes in the treatment of COVID-19. We aimed to explore the safety and efficiency of ...aerosol inhalation of the exosomes derived from human adipose-derived MSCs (haMSC-Exos) in patients with COVID-19.
The MEXCOVID trial is a phase 2a single-arm, open-labelled, interventional trial and patients were enrolled in Jinyintan Hospital, Wuhan, China. Eligible 7 patients were assigned to receive the daily dose of haMSCs-Exos (2.0 × 10
nano vesicles) for consecutively 5 days. The primary outcomes included the incidence of prespecified inhalation-associated events and serious adverse events. We also observed the demographic data, clinical characteristics, laboratory results including lymphocyte count, levels of D-dimer and IL-6 as well as chest imaging.
Seven severe COVID-19 related pneumonia patients (4 males and 3 females) were enrolled and received nebulized haMSC-Exos. The median age was 57 year (interquartile range (IQR), 43 year to 70 year). The median time from onset of symptoms to hospital admission and administration of nebulized haMSC-Exos was 30 days (IQR, 15 days to 40 days) and 54 d (IQR, 34 d to 69 d), respectively. All COVID-19 patients tolerated the haMSC-Exos nebulization well, with no evidence of prespecified adverse events or clinical instability during the nebulization or during the immediate post-nebulization period. All patients presented a slight increase of serum lymphocyte counts (median as 1.61 × 10
/L vs. 1.78 × 10
/L). Different degrees of resolution of pulmonary lesions after aerosol inhalation of haMSC-Exos were observed among all patients, more obviously in 4 of 7 patients.
Our trial shows that a consecutive 5 days inhalation dose of clinical grade haMSC-Exos up to a total amount of 2.0 × 10
nano vesicles was feasible and well tolerated in seven COVID-19 patients, with no evidence of prespecified adverse events, immediate clinical instability, or dose-relevant toxicity at any of the doses tested. This safety profile is seemingly followed by CT imaging improvement within 7 days. Further trials will have to confirm the long-term safety or efficacy in larger population.
MEXCOVID, NCT04276987.